BG
ATRA icon

BlackRock Group’s Atara Biotherapeutics ATRA Stock Holding History

BlackRock Group’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$86K Buy
240
+19
+9% +$8.04K ﹤0.01% 2854
2016
Q3 		$119K Buy
221
+8
+4% +$4.34K ﹤0.01% 2784
2016
Q2 		$121K Sell
213
-3
-1% -$1.44K ﹤0.01% 2727
2016
Q1 		$103K Buy
216
+94
+77% +$42.3K ﹤0.01% 2755
2015
Q4 		$80K Sell
122
-4
-3% -$3.03K ﹤0.01% 2741
2015
Q3 		$99K Buy
126
+44
+54% +$53.7K ﹤0.01% 2710
2015
Q2 		$109K Buy
+82
New +$94.1K ﹤0.01% 2729

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return